ProSomnus (ProSomnus) Debt-to-Equity : -1.08 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ProSomnus Debt-to-Equity?

ProSomnus's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.54 Mil. ProSomnus's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $37.83 Mil. ProSomnus's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-38.16 Mil. ProSomnus's debt to equity for the quarter that ended in Dec. 2023 was -1.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ProSomnus's Debt-to-Equity or its related term are showing as below:

OSAPQ' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.61 Med: -0.71 Max: -0.22
Current: -1.08

During the past 4 years, the highest Debt-to-Equity Ratio of ProSomnus was -0.22. The lowest was -1.61. And the median was -0.71.

OSAPQ's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs OSAPQ: -1.08

ProSomnus Debt-to-Equity Historical Data

The historical data trend for ProSomnus's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProSomnus Debt-to-Equity Chart

ProSomnus Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

-0.22

-0.33

-1.61

-1.08

ProSomnus Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial							-1.61	-1.30	-1.47	-1.23	-1.08

Competitive Comparison of ProSomnus's Debt-to-Equity

For the Medical Devices subindustry, ProSomnus's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProSomnus's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProSomnus's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ProSomnus's Debt-to-Equity falls into.

ProSomnus Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ProSomnus's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.538	+	37.831)	/	-38.156
	=	-1.08

ProSomnus's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.538	+	37.831)	/	-38.156
	=	-1.08

ProSomnus (OTCPK:OSAPQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

ProSomnus Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ProSomnus's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ProSomnus (ProSomnus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProSomnus Inc (OTCPK:OSAPQ) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

5675 Gibraltar Drive, Pleasanton, CA, USA, 94588

Website

https://www.prosomnus.com

ProSomnus Inc is a medical device manufacturer. It manufacturers precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are more comfortable and less invasive alternative to continuous positive airway pressure therapy, and lead to more effective and patient-preferred outcomes.

Executives

Sung Kim	officer: Chief Technical Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
John Steffens	10 percent owner	C/O DIGITALBRIDGE GROUP, INC., 750 PARK OF COMMERCE DRIVE SUITE 210, BOCCA RATON FL 33487
Gregory P. Ho	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Brian B Dow	officer: Chief Financial Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Smc Holdings Ii, Lp	10 percent owner	65 EAST 55TH STREET, 33RD FLOOR, NEW YORK NY 10022
Smc Holdings Ii G.p., Llc	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Laing Rikkers	director	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Len Liptak	director, officer: Chief Executive Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Mark Thomas Murphy	officer: Chief Growth Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Hgp Iii, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Steven Robert Pacelli	director	5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Hmc, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Healthpointcapital, Llc	10 percent owner	C/O HEALTHPOINTCAPITAL, 505 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Healthpointcapital Partners Iii Lp	10 percent owner	505 Park Avenue, 12th Floor, New York NY 10022
Leonard Hedge	director	7855 BELLA MONTANIA LANE, PALO CEDRO CA 96073